Who is it for?
Soft-tissue biopsy establishes the diagnosis of masses arising from muscle, fat or connective tissue. For masses that are indeterminate on imaging, fast-growing, deep-seated or beyond certain size, tissue diagnosis is the foundation of the treatment plan.
When a malignant soft-tissue tumor (sarcoma) is possible, PLANNING the biopsy matters especially: the needle track must be chosen in line with the incision of any future surgery. These biopsies are therefore planned in coordination with the treating surgical team — a core principle of international sarcoma guidelines.
How it is done — step by step
Planning
The mass is mapped with ultrasound (with MRI review when needed); the track is chosen in line with the possible surgical plan.
Local anaesthesia
Skin and track are numbed.
Sampling
Multiple cores are taken from viable-appearing parts of the mass under ultrasound guidance.
Finish
Compression and a small dressing; the entry point is documented.
What to expect on the day
Fasting is usually unnecessary; report blood thinners in advance.
The visit typically takes 20–30 minutes; you go home the same day after brief observation.
Risks and Limitations
Soreness and bruising at the site are most common; significant bleeding and infection are rare. For deep masses, neighbouring vessels and nerves are protected under continuous ultrasound vision.
A limit: occasionally the sample is insufficient or does not represent the most aggressive part; with pathology–imaging discordance, repeat biopsy or surgical sampling is decided. If sarcoma is confirmed, treatment is planned multidisciplinarily at an experienced centre.
Recovery and follow-up
You can return to daily life the same day; spare the site for 24 hours.
Pathology is usually ready within days to two weeks (special stains can extend this); results are reviewed with the orthopaedic oncology/surgical team.
Scientific References
- CIRSE — Perkütan İğne Biyopsisi Kılavuzu (Veltri A ve ark., Cardiovasc Intervent Radiol, 2017)
- ESMO-EURACAN-GENTURIS — Yumuşak doku ve visseral sarkom klinik uygulama kılavuzu (Gronchi A ve ark., Ann Oncol, 2021)
Frequently Asked Questions
Is every soft-tissue mass a tumor?
No — most are benign (such as lipomas). Biopsy brings clarity for fast-growing, deep, large or indeterminate masses.
Why does the needle track matter so much?
When sarcoma is possible, the track is placed along the line a future operation would remove. This planning is a core guideline principle, done with the surgical team.
Is it painful?
Done under local anaesthesia; most patients feel only pressure, and tenderness settles within days.
When is the result ready?
Usually within days to two weeks; special studies can extend this slightly.
Can biopsy spread the tumor?
With a properly planned core biopsy the seeding risk is very low, and aligning the track with surgery manages even the theoretical risk. No correct treatment can be built without tissue diagnosis.
What if it is a sarcoma?
Treatment proceeds with a multidisciplinary plan — surgery, oncology, radiotherapy — at an experienced centre. Biopsy is the first, mandatory step of that plan.
The information on this page is for general education; diagnosis and treatment decisions are made individually after clinical evaluation.